ArticleNeuro-oncology advances

Bevacizumab alternating chemotherapy for improving the survival of patients with recurrent high-grade glioma.

Ping-Chuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.